Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(13)
DRUG(3)
Carboplatin
4 trials
phase_2phase_3
fundación-gecp
Paclitaxel
3 trials
phase_2phase_3
fundación-gecp
Nivolumab
2 trials
phase_2phase_3
fundación-gecp
Durvalumab
1 trial
fundación-gecp
Sotorasib
1 trial
phase_2
fundación-gecp
Atezolizumab
1 trial
phase_2
fundación-gecp
Bintrafusp alfa
1 trial
phase_2
fundación-gecp
Cemiplimab
1 trial
phase_2
fundación-gecp

+2 more interventions

10 unique interventions2 categories

Analytics

Trial Phases

Phase 26
Phase 31

Trial Status

Completed2
Recruiting3
Other3

Role Distribution

Principal Investigator2
Other Roles6
PI Rate25%

Activity Timeline

Clinical Trials (8)

NCT06917573Phase 2Recruiting
PALACE: Cemiplimab Trial According to ctDNA Levels
Lung DiseasesNon Small Cell Lung Cancer MetastaticRespiratory Tract Neoplasms+3 more
StudychairStart date: 2025-07-29
NCT06634199Recruiting
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
Non-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation
StudychairStart date: 2024-10-03
NCT05684276Phase 2Active Not Recruiting
DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors
NSCLCPancoast Tumor
StudychairStart date: 2023-05-12
NCT05398094Phase 2Recruiting
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
KRAS P.G12CNon-small Cell Lung Cancer Stage III
StudychairStart date: 2022-03-21
NCT05005429Phase 2Completed
Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma
Mesothelioma; Lung
PrincipalinvestigatorStart date: 2021-09-20
NCT04776447Phase 2Completed
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)
Carcinoma Bronchiogenic Stage IIICarcinoma, Non-Small-Cell LungLung Diseases+4 more
StudychairStart date: 2021-06-16
NCT04564157Phase 3Active Not Recruiting
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy
Adjuvant ChemotherapyNon-Small Cell Lung Cancer
StudychairStart date: 2021-01-13
NCT04223596Phase 2Active Not Recruiting
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
Lung CancerNSCLCNSCLC Stage IIIB+1 more
PrincipalinvestigatorStart date: 2020-05-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNSCLCStage IIIB Non-small Cell Lung Cancer+1 more
Similarity Score6%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung CancerNSCLC
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer
Similarity Score3%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Lung DiseasesCarcinoma, Non-Small-Cell Lung
Similarity Score3%

Yongchang Zhang, MD

Hunan Cancer Hospital

Related
27 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung
Similarity Score3%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung
Similarity Score3%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer
Similarity Score3%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT06917573Phase 2StudyChair

PALACE: Cemiplimab Trial According to ctDNA Levels

Lung DiseasesNon Small Cell Lung Cancer MetastaticRespiratory Tract Neoplasms+3 more
Recruiting
NCT06634199StudyChair

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Non-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation
Recruiting
NCT05684276Phase 2StudyChair

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

NSCLCPancoast Tumor
Active Not Recruiting
NCT05398094Phase 2StudyChair

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

KRAS P.G12CNon-small Cell Lung Cancer Stage III
Recruiting
NCT05005429Phase 2PrincipalInvestigator

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

Mesothelioma; Lung
Completed
NCT04776447Phase 2StudyChair

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

Carcinoma Bronchiogenic Stage IIICarcinoma, Non-Small-Cell LungLung Diseases+4 more
Completed
NCT04564157Phase 3StudyChair

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Adjuvant ChemotherapyNon-Small Cell Lung Cancer
Active Not Recruiting
NCT04223596Phase 2PrincipalInvestigator

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

Lung CancerNSCLCNSCLC Stage IIIB+1 more
Active Not Recruiting

All 8 trials loaded